Metabolic parameters in cord blood of newborns of women with polycystic ovary syndrome

被引:27
作者
Maliqueo, Manuel [1 ]
Echiburu, Barbara [1 ]
Crisosto, Nicolas [1 ]
Amigo, Pablo [1 ]
Aranda, Pablo [1 ]
Sanchez, Fernando [1 ]
Sir-Petermann, Teresa [1 ]
机构
[1] Univ Chile, West Div, Sch Med, Endocrinol & Metab Lab, Santiago, Chile
关键词
Polycystic ovary syndrome; cord blood; leptin; FOR-GESTATIONAL-AGE; INTRAUTERINE GROWTH-RETARDATION; LEPTIN CONCENTRATIONS; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; PLASMA LEPTIN; PREGNANCY COMPLICATIONS; DIABETIC MOTHERS; MATERNAL SERUM; BIRTH-WEIGHT;
D O I
10.1016/j.fertnstert.2008.04.022
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To assess metabolic parameters in the cord blood of newborns of women with polycystic ovary syndrome (PCOS) and to correlate these parameters with those of mothers with PCOS during midgestation. Design: Case-control study. Setting: Unit of Endocrinology and Reproductive Medicine. Patient(s): Thirty newborns of mothers with PCOS (PCOSn) and 34 newborns of control mothers (Cn) were studied. Intervention(S): A sample of cord blood was obtained at delivery. In all mothers, an oral glucose tolerance test (oGTT) with measurement of glucose and insulin was performed at 22-28 weeks of gestation. In cord blood and in the fasting sample of the oGTT. serum leptin, adiponectin, insulin, glucose, and lipids (triglycerides, cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol) were determined. Result(s): PCOSn showed significantly higher leptin concentrations than Cn. Moreover, in PCOSn, leptin concentrations in cord blood were correlated with birth weight (r = 0.495) and body mass index of the mother at midpregnancy (r = 0.644). Conclusion(S): The metabolic parameters in the cord blood of PCOSn are similar to those observed in controls, except for leptin concentrations, which are significantly higher. The latter could be related to the fetal adiposity or the metabolic condition of the mother. (Fertil Steril (R) 2009;92:277-82. (C) 2009 by American Society for Reproductive Medicine.)
引用
收藏
页码:277 / 282
页数:6
相关论文
共 51 条
[1]   PREVALENCE OF POLYCYSTIC OVARIES IN WOMEN WITH ANOVULATION AND IDIOPATHIC HIRSUTISM [J].
ADAMS, J ;
POLSON, DW ;
FRANKS, S .
BRITISH MEDICAL JOURNAL, 1986, 293 (6543) :355-359
[2]  
[Anonymous], 1999, WHO CONS DEF DIAGN 1
[3]   Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome [J].
Bjercke, S ;
Dale, PO ;
Tanbo, T ;
Storeng, R ;
Ertzeid, G ;
Åbyholm, T .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2002, 54 (02) :94-98
[4]   A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome [J].
Boomsma, C. M. ;
Eijkemans, M. J. C. ;
Hughes, E. G. ;
Visser, G. H. A. ;
Fauser, B. C. J. M. ;
Macklon, N. S. .
HUMAN REPRODUCTION UPDATE, 2006, 12 (06) :673-683
[5]   Sexual dimorphism in the levels of amniotic fluid leptin in pregnancies at 16 weeks of gestation - Relation to fetal growth [J].
Cagnacci, A ;
Arangino, S ;
Caretto, S ;
Mazza, V ;
Volpe, A .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2006, 124 (01) :53-57
[6]   Fetal plasma leptin concentrations: Relationship with different intrauterine growth patterns from 19 weeks to term [J].
Cetin, I ;
Morpurgo, PS ;
Radaelli, T ;
Taricco, E ;
Cortelazzi, D ;
Bellotti, M ;
Pardi, G ;
Beck-Peccoz, P .
PEDIATRIC RESEARCH, 2000, 48 (05) :646-651
[7]   Cord blood leptin and insulin-like growth factor levels are independent predictors of fetal growth [J].
Christou, H ;
Connors, JM ;
Ziotopoulou, L ;
Hatzidakis, V ;
Papathanassoglou, E ;
Ringer, SA ;
Mantzoros, CS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) :935-938
[8]  
Cinaz P, 1999, ACTA PAEDIATR, V88, P753, DOI 10.1080/08035259950169044
[9]   Abnormal fetal growth: intrauterine growth retardation, small for gestational age, large for gestational age [J].
Das, UG ;
Sysyn, GD .
PEDIATRIC CLINICS OF NORTH AMERICA, 2004, 51 (03) :639-+
[10]   Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) [J].
Fauser, BCJM ;
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
HUMAN REPRODUCTION, 2004, 19 (01) :41-47